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Abstract
Aberrant c-aminobutyric acid type A (GABAA) receptor-mediated inhibition in cortico-thalamic networks remains an
attractive mechanism for typical absence seizure genesis. Using the whole-cell patch clamp technique we examined ‘phasic’
and ‘tonic’ GABAA inhibition in thalamocortical neurons of somatosensory (ventrobasal, VB) thalamus, nucleus reticularis
thalami (NRT) neurons, and layer 5/6 pyramidal neurons of the somatosensory (barrel) cortex of succinic semialdehyde
dehydrogenase (SSADH) knock-out (SSADH2/2) mice that replicate human SSADH deficiency and exhibit typical absence
seizures. We found increased sIPSC frequency in both VB and NRT neurons and larger sIPSC amplitude in VB neurons of
SSADH2/2 mice compared to wild-type animals, demonstrating an increase in total phasic inhibition in thalamus of
SSADH2/2 mice. mIPSCs in both VB and NRT neurons were no different between genotypes, although there remained a
trend toward more events in SSADH2/2 mice. In cortical layer 5/6 pyramidal neurons, sIPSCs were fewer but larger in
SSADH2/2 mice, a feature retained by mIPSCs. Tonic currents were larger in both thalamocortical neurons and layer 5/6
pyramidal neurons from SSADH2/2 mice compared to WTs. These data show that enhanced, rather than compromised,
GABAA receptor-mediated inhibition occurs in cortico-thalamic networks of SSADH
2/2 mice. In agreement with previous
studies, GABAA receptor-mediated inhibitory gain-of-function may be a common feature in models of typical absence
seizures, and could be of pathological importance in patients with SSADH deficiency.
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Introduction
Succinic semialdehyde dehydrogenase (SSADH) deficiency is
an autosomal recessively inherited disorder which, when
compared with other neurometabolic disorders, is relatively
common with approximately 400 identified cases worldwide [1].
Loss of SSADH activity compromises GABA degradation,
leading to the accumulation not only of GABA but also of c-
hydroxybutyric acid (GHB) in the cerebrospinal fluid [1,2].
Clinical symptoms of SSADH deficiency are variable, but
typically include delayed intellectual, speech and language
development, hypotonia, ataxia, sleep disturbances and an array
of epilepsies, including generalized tonic-clonic, absence and
myoclonic seizures [3–5]. Recently, SSADH deficient mice were
developed that replicate the GHB and GABA accumulation
exhibited in humans, and have a strikingly similar epileptic
phenotype [1,6,7]. In particular, homozygous SSADH knock-out
(SSADH2/2) mice display typical absence seizures that appear at
the beginning of the third postnatal week, evolve into myoclonic
and generalized convulsive seizures, and finally progress to lethal
status epilepticus [6,8,9]. These mice are therefore a valuable tool
in examining the pathological cellular mechanisms underlying
seizure genesis in SSADH deficiency.
Typical absence seizures characterize many idiopathic gener-
alized epilepsies and are generated in cortico-thalamic networks
[10,11]. In rodent models, spike-and-wave discharges, the EEG
hallmark of absence seizures, arise in layer 5/6 neurons of the
somatosensory cortex and propagate to the underlying thalamus
[12–14]. However, recruitment of thalamocortical neurons of the
somatosensory ventrobasal (VB) nucleus and neurons of the
nucleus reticularis thalami (NRT) is required for the full
electrographic and behavioural expression of seizures [13].
Whilst compromised GABAergic inhibition in cortico-thalamic
networks is an attractive pathological mechanism for seizure
genesis [15,16], we recently demonstrated that extrasynaptic
GABAA receptor-mediated inhibition is increased in thalamocor-
tical neurons from multiple and diverse models of absence
seizures, and that extrasynaptic GABAA receptor hyperfunction
in the thalamus is critical for seizure genesis [17]. Extrasynaptic
GABAA receptors generate a distinct type of inhibition from their
synaptic counterparts. Synaptic GABAA receptors are activated
by vesicular GABA release from GABAergic terminals and
generate classical ‘phasic’ inhibitory post-synaptic currents
(IPSCs). By comparison, extrasynaptic GABAA receptors are
activated by spillover of GABA from the synaptic cleft and
generate a persistent or ‘tonic’ GABAA current [18,19]. Previous
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studies in SSADH2/2 mice have observed altered phasic and
tonic GABAA inhibition in hippocampal CA1 pyramidal and
cortical layer 2/3 pyramidal neurons [20–22], but whilst these
findings may have relevance for the development of myoclonic
and generalized convulsive seizures, GABAA receptor-mediated
inhibition has not been examined in neurons that actively
participate in the generation of typical absence seizures, i.e.
thalamocortical neurons, NRT neurons and layer 5/6 pyramidal
neurons. We have therefore examined phasic and tonic GABAA
currents in thalamic and cortical neurons from SSADH2/2 mice
and compared them to wild-type (WT) littermates. Our data
demonstrate altered GABAA receptor-mediated inhibition in all
three neuron types that may underlie the appearance of absence
seizures in SSADH2/2 mice and be of pathological importance
in human SSADH deficiency.
Methods
All animal procedures were carried out in accordance with local
ethical committee guidelines (Cardiff University Reseach Ethics
Committee) and the U.K. Animals (Scientific Procedure) Act,
1986 (Home Office Project License Number PPL 30/2413). All
efforts were made to minimize the suffering and number of
animals used in each experiment.
Breeding pairs of heterozygous SSADH deficient mice were
obtained from Jackson Laboratories (Bar Harbor, ME, U.S.A).
Offspring were genotyped as described previously [6], and
experiments performed on postnatal day (P)23–31 SSADH2/2
and WT littermates. Despite initial reports of lethal status
epilepticus occurring in SSADH2/2 mice from the end of the
third postnatal week [6,21], inbreeding of subsequent generations
has ameliorated the severity of this phenotype so that mice are
now capable of surviving into adulthood [23].
Slice preparation and electrophysiology
Horizontal slices containing the VB thalamus and NRT, or
coronal slices containing the somatosensory (barrel) cortex were
prepared as described previously [26]. Briefly, male and female
WT and SSADH2/2 mice were anaesthetised with isoflurane
and decapitated. The brain was rapidly removed and slices cut in
ice-cold, continuously oxygenated (95% O2: 5% CO2) artificial
cerebrospinal fluid (aCSF) containing (in mM): NaCl 85,
NaHCO3 26, KCl 2.5, NaH2PO4 1.25, MgCl2 2, CaCl2 2,
glucose 10, sucrose 73.6, kynurenic acid 3, and indomethacin
0.045. Kynurenic acid and indomethacin were included in the
cutting medium in order to improve slice viability [17]. Slices
were incubated at room temperature in the above aCSF, but
without kynurenic acid and indomethacin, for 15 mins before
the sucrose-containing aCSF was gradually replaced over a
period of 4–6 hrs with continuously oxygenated aCSF containing
(in mM): NaCl 126, NaHCO3 26, KCl 2.5, NaH2PO4 1.25,
MgCl2 2, CaCl2 2, and glucose 10. Slices were further incubated
for at least 1 hr before being transferred to the recording
chamber and perfused with warmed (3361uC), continuously
oxygenated aCSF containing (in mM): NaCl 126, NaHCO3 26,
KCl 2.5, NaH2PO4 1.25, MgCl2 1, CaCl2 2, glucose 10, and
kynurenic acid 3.
Neurons were visualised using a Nikon microscope (Eclipse
E600FN; Tokyo, Japan) equipped with a 406 immersion lens
and a video camera (Hamamatsu, Hamamatsu City, Japan). The
rodent VB thalamus and NRT contain a relatively uniform
population of thalamocortical and GABAergic neurons, respec-
tively [24,25], whilst cortical layer 5/6 pyramidal neurons were
identified by their characteristic shape and the presence of a
large apical dendrite. Whole-cell patch clamp recordings were
made using pipettes pulled from standard wall borosilicate glass
(GC120F-10; Harvard Apparatus, Edenbridge, Kent, U.K.)
attached to the headstage of a Multiclamp 700B amplifier
controlled by Multiclamp Commander software (Molecular
Devices, Sunnyvale, CA, U.S.A). Pipettes had a tip resistance
of 2–4 MV when filled with solution containing (in mM): CsCl
130, MgCl2 2, Mg-ATP 4, Na-GTP 0.3, HEPES 10, and EGTA
0.1; pH 7.25–7.30, ,290 mOsm. Neurons were held at
270 mV, and since the reversal potential of Cl2 was ,0 mV
GABAA currents appeared inward. Series resistance and whole-
cell capacitance were determined in response to 5 mV voltage
steps. Series resistance was compensated by ,80%, and
recordings discarded if it increased by .30%. Data were
digitized at 20 kHz (Digidata 1322A, Molecular Devices),
acquired using pClamp 9.0 software (Molecular Devices), and
stored on a personal computer.
Data analysis
Data were analysed as described previously [17,26]. Briefly,
data were filtered at 3 kHz and converted to an ASCII format for
analysis using LabView based software (National Instruments,
Austin, TX, U.S.A.). For analysis of spontaneous and miniature
IPSCs, populations of individual IPSCs were averaged, and the
peak amplitude, charge transfer (the integral of the average IPSC),
weighted decay time constant (integral of the average IPSC
divided by peak amplitude), frequency, and total current (charge
transfer 6 frequency) measured. Tonic GABAA currents were
revealed as a shift in baseline current following the focal
application of the GABAA antagonist 6-imino-3-(4-methoxyphe-
nyl)-1-(6H)-pyridazinebutanoic acid hydrobromide (gabazine). To
measure tonic current amplitude, 5 ms epochs of baseline current
were sampled every 100 ms, and those epochs that fell on IPSCs
discarded. The average baseline current was then determined for
two 5 s periods before gabazine application (i and ii) and one
period after (iii). The background ‘drift’ of the baseline current was
then calculated as the difference between the two pre-gabazine
periods (i.e. ii-i), and the ‘shift’ in baseline current due to block of a
tonic GABAA current as the difference between the second pre-
gabazine period and the post-gabazine period (i.e. iii-ii). A tonic
current was presumed to be present for a given neuron if the post-
gabazine shift was greater than twice the standard deviation of the
pre-gabazine drift. The presence of tonic currents in a population
of neurons (i.e. pre-gabazine drift vs. post-gabazine shift) was tested
using Student’s paired t-test, with significance set at P,0.05.
Tonic current amplitude was also normalized to the whole-cell
capacitance for each neuron.
To compare the post-natal age of WT and SSADH2/2 mice,
absolute and normalized tonic current amplitudes, spontaneous
and miniature IPSC properties between genotypes, and the effects
of tetrodotoxin alone or together with (2S)-3-[[(1S)-1-(3,4-dichlor-
ophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphonic
acid (CGP55845) on tonic current amplitude and IPSC
properties within genotypes, we used Student’s unpaired t-test
with significance set at P,0.05. Differences in the distribution of
inter-IPSC intervals between genotypes were compared using the
Kolmogorov-Smirnov test, with significance set at P,0.05. Data
are presented as mean 6 s.e.m.
Gabazine was focally applied to the slice using a pipette.
Tetrodotoxin and CGP55845 were bath applied. CGP558945 was
initially dissolved in DMSO before addition to the aCSF.
Gabazine and tetrodotoxin were obtained from Ascent Scientific
(Bristol, U.K.) and CGP55845 from Tocris (Bristol, U.K.).
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Results
Data were obtained from 19 WT and 14 SSADH2/2 mice. The
mean age was not significantly different between the two
genotypes (WT: 25.760.5 days, SSADH2/2: 25.060.5 days).
Thalamocortical neurons
Under control conditions, i.e. in the presence of kynurenic acid
(3 mM) to block ionotropic glutamate receptors and isolate
GABAA receptor mediated currents (Cope et al., 2009), sIPSCs
were readily apparent in thalamocortical neurons of the VB
thalamus from both WT (n = 11 cells) and SSADH2/2 (n = 9
cells) mice (Fig. 1A and Table 1), as described previously
[17,26,27]. Comparison of sIPSC properties between WT and
SSADH2/2 mice showed that peak amplitude, frequency, charge
transfer and total current were significantly larger in SSADH2/2
mice (all P,0.05) (Table 1). Furthermore, there was a significant
difference in the distribution of inter-IPSC intervals between WT
and SSADH2/2 mice (P,0.001), so that shorter inter-IPSC
intervals were more prevalant in SSADH2/2 mice (Fig. 1B). We
also measured tonic GABAA currents in the same thalamocortical
neurons following the focal application of the GABAA antagonist
gabazine (GBZ, 50 mM) (Fig. 1C) [17,26,27]. Tonic currents were
observed in every neuron recorded from both WT and
SSADH2/2 mice, but were significantly larger in SSADH2/2
mice compared to WTs (WT: 139.2621.6 pA, SSADH2/2:
Figure 1. Increased tonic GABA currents and altered IPSC properties in TC neurons of SSADH2/2mice. A, representative current traces
from thalamocortical neurons of wild-type (WT, top) and SSADH2/2 (bottom) mice showing the differences in spontaneous IPSC frequency and
amplitude between the two genotypes. B, cumulative probability plot showing the distribution of inter-IPSC intervals under control conditions (Con)
(WT, thin line, 10678 inter-IPSC intervals; SSADH2/2, thick line, 11337 inter-IPSC intervals) and in the presence of 0.5 mM TTX (WT, thin dashed line,
5767 inter-IPSC intervals; SSADH2/2, thick dashed line, 7138 inter-IPSC intervals). C, representative current traces from thalamocortical neurons of WT
(left) and SSADH2/2 (right) mice showing the difference in tonic current amplitude between the two genotypes. Dotted lines represent the initial
baseline current prior to the focal application of 50 mM GBZ (white bar). D, graph comparing absolute tonic current amplitude in WT and SSADH2/2
mice under control conditions (Con, white columns), and in the presence of TTX (black columns). E, graph comparing normalized tonic current
amplitude between WT and SSADH2/2 mice under control conditions (Con) and in the presence of TTX. D and E, * P,0.05, ** P,0.01 and
*** P,0.001 WT vs. SSADH2/2, Student’s unpaired t-test.
doi:10.1371/journal.pone.0019021.g001
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191.5612.1 pA; P,0.05) (Fig. 1C and D). Tonic current
amplitude remained significantly larger in SSADH2/2 mice
when normalized to whole-cell capacitance (WT: 2.460.3 pA/
pF, SSADH2/2: 3.660.3 pA/pF; P,0.05) (Fig. 1E). Interest-
ingly, in heterozygous animals (SSADH+/2) the tonic current in
thalamocortical neurons was slightly, but not significantly
(P.0.05), larger than WT animals but less than (P,0.05) that
observed in SSADH2/2 (SSADH+/2: 147.1619.8 pA; Normal-
ised: 2.660.4 pA/pF). This finding is consistent with previously
published data in dentate gyrus granule cells that also showed the
magnitude of tonic GABAergic inhibition is dependent upon
SSADH ‘gene dosage’ [28].
We also measured mIPSC properties in thalamocortical
neurons following bath application of tetrodotoxin (TTX,
0.5 mM). Comparison of mIPSC properties between WT
(n = 10 cells) and SSADH2/2 (n = 10 cells) mice revealed no
significant differences (Table 1), although the distribution of inter-
IPSC intervals was significantly different between the two
genotypes (P,0.001), indicating a trend for a higher mIPSC
frequency in SSADH2/2 animals (Fig. 1B). In both WT and
SSADH2/2 mice there was a general trend for the frequency of
mIPSCs to be reduced compared to sIPSCs, but this was only
significant for SSADH2/2 mice (SSADH2/2: P,0.01; WT:
P = 0.07), and for the weighted decay time constant to be faster,
but this was only significant for WT mice (Table 1). In addition
the charge transfer and total current of mIPSCs was significantly
smaller in SSADH2/2 mice compared to sIPSCs (P,0.05 and
P,0.01, respectively) (Table 1). Tonic current amplitude in the
same thalamocortical neurons was also reduced in both strains
compared to control conditions (WT: 92.8615.1 pA, SSADH2/2:
167.5617.9 pA), but not significantly (Fig. 1D). Similarly, the
normalized tonic current amplitude in both genotypes was also not
significantly different compared to control conditions (WT:
1.761.0 pA/pF, SSADH2/2: 4.060.4 pA/pF) (Fig. 1E). However,
both absolute and normalized tonic current amplitude were still
significantly larger in SSADH2/2 compared to WT mice in the
presence of TTX (absolute P,0.01, normalized P,0.001) (Fig. 1D
and E). Thus, increased phasic and tonic GABAA receptor-
mediated inhibition occurs in thalamocortical neurons of the
somatosensory thalamus from SSADH2/2 mice.
NRT neurons
The frequency of sIPSCs in NRT neurons from both WT and
SSADH2/2 mice was lower compared to thalamocortical neurons
(compare Figs. 1A and 2A, and Tables 1 and 2), in agreement with
previous studies in rodents [26,27,29,30]. Furthermore, sIPSCs in
NRT neurons exhibited a characteristically slower decay com-
pared to those in thalamocortical neurons (Fig. 2B). Comparison
of NRT neuron sIPSC properties between WT and SSADH2/2
mice (n = 9 and 6 cells, respectively) showed that sIPSC frequency
and total current were significantly larger in SSADH2/2 mice
(both P,0.05) (Fig. 2A and Table 2). In agreement with this, the
distribution of inter-IPSC intervals between WT and SSADH2/2
mice was significantly different (P,0.001) so that shorter inter-
IPSC intervals were more apparent in SSADH2/2 mice (Fig. 2C).
Similar to thalamocortical neurons, we focally applied GBZ to
NRT neurons of both genotypes (n = 3 cells each), to test for the
presence of tonic currents. However, tonic currents were never
observed (data not shown), in agreement with previous studies in
NRT neurons [26,27].
In the presence of 0.5 mM TTX, the parameters of mIPSCs
recorded from NRT neurons were not significantly different
between WT and SSADH2/2 mice (n = 9 and 6 cells, respective-
ly). However, there was a clear trend for mIPSC frequency to be
greater in SSADH2/2 mice compared to WTs (P = 0.07), that was
reflected in the significantly different distribution of inter-IPSC
intervals between genotypes (P,0.001) (Fig. 2C). There were no
differences in the properties of sIPSCs and mIPSCs in WT mice,
but mIPSCs in SSADH2/2 mice had a significantly smaller
charge transfer compared to sIPSCs (P,0.05) (Table 2). Since we
did not observe tonic currents in NRT neurons under control
conditions, we did not test for their presence following the
Table 1. Comparison of spontaneous and miniature IPSC properties, and the effects of CGP55845 on miniature IPSCs, in
thalamocortical neurons of the ventrobasal thalamus from wildtype (WT) and SSADH2/2 mice.
IPSC parameter
n
Peak amplitude
(pA)
Weighted decay
(ms)
Frequency
(Hz)
Charge transfer
(fC)
Total current
(pA)
sIPSCs
WT (11) 252.563.2 1.860.1 18.563.6 2106.967.7 21.960.4
SSADH2/2 (9) 283.964.7*** 1.660.1 33.666.6* 2162.3615.7** 25.461.1**
mIPSCs
WT (10) 261.564.1 1.460.1{{{ 10.562.2 299.568.3 21.160.3
SSADH2/2 (10) 273.567.6 1.460.1 13.061.3{{ 2120.2613.7{ 21.660.2{{
mIPSCs + CGP55845
WT (11) 257.763.8 1.660.1{ 10.461.4 2104.267.9 21.260.2
SSADH2/2 (7) 277.6613.5 1.760.2 8.561.8{ 2167.5649.0 21.360.3
Data are presented as mean 6 s.e.m.
*P,0.05,
**P,0.01 and
***P,0.001, WT vs. SSADH2/2.
{P,0.05,
{{P,0.01 and
{{{P,0.001, sIPSCs vs. mIPSCs within genotypes.
{P,0.05, mIPSCs vs. mIPSCs+CGP55845 within genotypes. Number of recorded neurons (n) is as indicated.
doi:10.1371/journal.pone.0019021.t001
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application of TTX. These results demonstrate increased phasic
GABAA inhibition in NRT neurons of SSADH
2/2 mice
compared to WT littermates.
Layer 5/6 pyramidal neurons
Comparison of sIPSCs in layer 5/6 pyramidal neurons of the
somatosensory cortex from WT (n = 9 cells) and SSADH2/2
(n = 9 cells) mice revealed a significantly larger peak amplitude and
charge transfer in SSADH2/2 mice (Fig. 3A and Table 3)
(P,0.001 and P,0.05, respectively), and although there was no
difference in sIPSC frequency between genotypes, the distribution
of inter-IPSC intervals was significantly different (P,0.001) in
favour of shorter inter-IPSC intervals in WT mice (Fig. 3B). In the
same neurons from WT mice, focal application of GBZ failed to
reveal a tonic current (absolute 4.861.2 pA, normalized
0.260.1 pA/pF) (Fig. 3C–E), as described previously for layer
2/3 pyramidal neurons in these WT mice [21]. In contrast, focal
application of GBZ in SSADH2/2 mice revealed robust tonic
currents (absolute 35.066.1 pA, normalized 1.360.2 pA/pF)
(Fig. 3C) that were significantly larger compared to WT mice
(absolute and normalized, both P,0.001) (Fig. 3D and E).
In the presence of TTX, the peak amplitude and charge transfer
of mIPSCs recorded from layer 5/6 pyramidal neurons were
larger in SSADH2/2 mice (n = 7 cells) compared to WT mice
(n = 7 cells) (both P,0.05) (Table 3), and the distribution of inter-
IPSC intervals was also significantly different (P,0.001), indicat-
ing shorter inter-IPSC intervals in WT mice (Fig. 3B). In WT
mice, the frequency and total current of mIPSCs were significantly
smaller compared to sIPSCs (both P,0.05), but there was no
difference in the properties of mIPSCs and sIPSCs in SSADH2/2
mice (Table 3). Tonic currents in WT mice were still not apparent
in the presence of TTX (absolute 4.361.3 pA, normalized
0.260.1 pA/pF) (Fig. 3D and E), and TTX had no effect on
absolute and normalised tonic current amplitude in SSADH2/2
mice compared to control conditions (absolute 35.866.3 pA,
normalized 1.460.3 pA/pF) (Fig. 3D and E). However, absolute
and normalized tonic current amplitudes in the presence of TTX
remained significantly larger in SSADH2/2 mice compared to
WTs (both P,0.001). Thus, both spontaneous and miniature
IPSCs are larger, but fewer, in layer 5/6 pyramidal neurons of
SSADH2/2 mice compared to WTs, and SSADH2/2 mice also
exhibit larger tonic currents.
Figure 2. Increased IPSC frequency in NRT neurons of SSADH2/2
mice. A, representative current traces from NRT neurons of wild-type
(WT, top) and SSADH2/2 (bottom) mice showing the difference in
spontaneous IPSC frequency between the two genotypes. B, the
waveforms of average spontaneous IPSCs from a thalamocortical (TC)
neuron of the VB thalamus and an NRT neuron. Note the character-
istically slower decay of the IPSC from the NRT neuron compared to the
thalamocortical neuron. IPSCs have been normalized to the same peak
amplitude. C, cumulative probability plot showing the distribution of
inter-IPSC intervals under control conditions (Con) (WT, thin line, 1936
inter-IPSC intervals; SSADH2/2, thick line, 1710 inter-IPSC intervals) and
in the presence of 0.5 mM TTX (WT, thin dashed line, 1759 inter-IPSC
intervals; SSADH2/2, thick dashed line, 2143 inter-IPSC intervals).
doi:10.1371/journal.pone.0019021.g002
Table 2. Comparison of spontaneous and miniature IPSC properties in NRT neurons of wildtype (WT) and SSADH2/2 mice.
IPSC parameter
n
Peak amplitude
(pA)
Weighted decay
(ms)
Frequency
(Hz)
Charge transfer
(fC)
Total current
(pA)
sIPSCs
WT (9) 236.463.2 12.360.4 1.860.4 2456.8644.5 20.960.3
SSADH2/2 (6) 243.263.1 12.760.4 3.560.6* 2559.3634.9 22.060.5*
mIPSCs
WT (9) 240.762.9 12.860.7 1.660.2 2525.8639.1 20.960.1
SSADH2/2 (6) 235.563.2 12.560.8 3.961.5 2443.8623.8{ 21.860.7
Data are presented as mean 6 s.e.m.
*P,0.05, WT vs. SSADH2/2.
{P,0.05, sIPSCs vs. mIPSCs within genotypes. Number of recorded neurons (n) is as indicated.
doi:10.1371/journal.pone.0019021.t002
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Block of GABAB receptors reduces tonic current
amplitude in TC neurons of SSADH2/2 but not WT mice
Previously, we described a role for GABABRs in facilitation of
tonic eGABAAR currents in TC neurons of several animal models
of typical absence seizures including the Genetic Absence Epilsepy
Rat from Strasbourg (GAERS) and stargazer and lethargic mice
[17]. As SSADH deficiency leads not only to increased GABA
concentration in the CSF but also increased GHB (a GABABR
agonist) levels we tested the contribution of GABABRs to the
enhancement of tonic GABAA current observed in TC neurons of
SSADH2/2mice. In the presence of TTX the GABABR antagonist
CGP55845 (10 mM) produced a significant reduction in mIPSC
frequency in VB TC neurons from SSADH2/2 mice but not in
those from WT mice (P,0.01) (Table 1) without significant
(P.0.05) differences in amplitudes of synaptic currents in either
mouse. In WT mice CGP55845 also resulted in a significant
increase (P,0.01) in the weighted decay time of mIPSCs, a trend
which was also observed in SSADH2/2 mice (although differences
were not significant, P.0.05). Importantly, in the same neurons
CGP55845 caused a significant reduction in the enhanced tonic
current observed in SSADH2/2 mice (TTX: 167.5617.9 pA,
n = 10; TTX+CGP: 74.368.5 pA, n = 7; P,0.001) but not in WT
littermates (TTX: 92.9615.1 pA, n = 10; TTX+CGP: 96.56
15.7 pA, n = 11; P.0.05) (Fig. 4). These findings indicated that in
SSADH2/2 mice GABABR-dependent modulation of tonic
GABAA currents in VB TC neurons may contribute to the
observed absence epilepsy phenotype as has been demonstrated in
other models of this pathological state.
Figure 3. Increased tonic GABA current and IPSC frequency in layer V cortical neurons in SSADH2/2 mice. A, representative current
traces from layer 5/6 pyramidal neurons of wild-type (WT, top) and SSADH2/2 (bottom) mice showing the difference in spontaneous IPSC amplitude
between the two genotypes. B, cumulative probability plot showing the distribution of inter-IPSC intervals under control conditions (Con) (WT, thin
line, 9356 inter-IPSC intervals; SSADH2/2, thick line, 6245 inter-IPSC intervals) and in the presence of 0.5 mM TTX (WT, thin dashed line, 3430 inter-IPSC
intervals; SSADH2/2, thick dashed line, 2977 inter-IPSC intervals). C, representative current traces from layer 5/6 pyramidal neurons of WT (left) and
SSADH2/2 (right) mice showing the difference in tonic current amplitude between the two genotypes. Note that a tonic current is not apparent in
the neuron from the WT animal. Dotted lines represent the initial baseline current prior to the focal application of 50 mM GBZ (white bar). D, graph
comparing absolute tonic current amplitude in WT and SSADH2/2 mice under control conditions (Con, white columns), and in the presence of TTX
(black columns). E, graph comparing normalized tonic current amplitude between WT and SSADH2/2 mice under control conditions (Con) and in the
presence of TTX. D and E, *** P,0.001 WT vs. SSADH2/2, Student’s unpaired t-test.
doi:10.1371/journal.pone.0019021.g003
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Discussion
Typical absence seizures are a clinical phenotype of many
idiopathic generalized epilepsies, and although several GABAA
receptor subunit mutations in cohorts of patients with absence
have been identified [31–34], and a causative role of compromised
GABAA receptor-mediated inhibition in seizure genesis has been
suggested [15,16], it is apparent that GABAA receptor gain-of-
function in cortico-thalamic networks may be an underlying
mechanism for these seizures [17,35–37]. The data presented here
support these findings by identifying increased phasic and tonic
GABAA inhibition in the principal cell types involved in the
generation of typical absence seizures from SSADH2/2 mice, a
rodent model of SSADH deficiency. In thalamocortical neurons of
SSADH2/2 mice, sIPSC frequency and peak amplitude were
greater, and in NRT neurons sIPSC frequency was also greater,
leading to increased total phasic current in both cell types. Block of
action potential-dependent GABA release by TTX effectively
normalised IPSC properties in both thalamocortical and NRT
neurons so that mIPSCs in SSADH2/2 mice were no different to
Table 3. Comparison of spontaneous and miniature IPSC properties in somatosensory cortical layer 5/6 pyramidal neurons from
wildtype (WT) and SSADH2/2 mice.
IPSC parameter n
Peak amplitude
(pA)
Weighted decay
(ms)
Frequency
(Hz)
Charge transfer
(fC)
Total current
(pA)
sIPSCs
WT (9) 262.465.3 2.460.2 18.963.2 2166.4623.8 23.260.7
SSADH2/2 (9) 296.966.4*** 2.660.4 12.663.0 2261.9628.3* 22.860.4
mIPSCs
WT (7) 270.465.5 2.160.3 8.962.2{ 2164.6628.2 21.460.3{
SSADH2/2 (7) 289.468.0* 3.060.5 7.861.9 2286.9642.4* 22.060.5
Data are presented as mean 6 s.e.m.
*P,0.05 and
***P,0.001, WT vs. SSADH2/2.
{P,0.05, sIPSCs vs. mIPSCs within genotypes. Number of recorded neurons (n) is as indicated.
doi:10.1371/journal.pone.0019021.t003
Figure 4. Contribution of GABAB receptors to enhanced tonic inhibition in TC neurons of SSADH
2/2 mice. A, representative current
traces from TC neurons of wild-type (WT, left) and SSADH2/2 (right) mice in the continuing presence of 0.5 mM TTX+10 mM CGP55845 (grey bar). Note
the tonic current is smaller in the neuron from the SSADH2/2 mouse compared to the WT mouse. Dotted lines represent the initial baseline current
prior to the focal application of 50 mM GBZ (white bar). B, graph comparing absolute tonic current amplitude in WT and SSADH2/2 mice in the
presence of TTX alone (TTX, black columns), and in the presence of TTX+CGP55845 (TTX+CGP., grey columns). C, graph comparing normalized tonic
current amplitude in WT and SSADH2/2 mice in the presence of TTX alone (TTX) and in the presence of TTX+CGP55845 (TTX+CGP.). B and C,
*** P,0.001 TTX vs. TTX+CGP. within genotypes, Student’s unpaired t-test.
doi:10.1371/journal.pone.0019021.g004
Increased GABAA Inhibition in SSADH Deficient Mice
PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e19021
those in WTs. Therefore increased phasic inhibition in thalamic
neurons of SSADH2/2 mice appears to be largely driven by
enhanced activity-dependent GABA release. However, in both
thalamocortical and NRT neurons, mIPSC frequency, as
determined by the distribution of inter-IPSC intervals, was indeed
greater in SSADH2/2 mice, perhaps also indicating an activity-
independent increase in vesicular GABA release. This is of
particular interest since NRT neurons are the primary source of
GABAergic input to the rodent VB thalamus [24,38] and also
innervate one another [39] but whereas GABAergic synapses in
the VB thalamus are axo-dendritic, GABAergic synapses in the
NRT are dendro-dendritic [39]. Therefore, despite this funda-
mental difference in synapse physiology, both types of synapse
appear to share GABA release mechanisms that are altered in
SSADH2/2 mice, perhaps preferentially at dendro-dendritic
synapses. In layer 5/6 pyramidal neurons, there was a clear trend
for spontaneous and miniature IPSC frequencies to be lower in
SSADH2/2 mice compared to WTs, as measured by the
distribution of inter-IPSC intervals, but the peak amplitude of
both sIPSCs and mIPSCs was significantly larger in the mutant
mice, effectively negating the change in frequency so that total
phasic current was no different between genotypes. The increased
peak amplitude in the presence of TTX therefore indicates that
GABAA receptor number is increased in layer 5/6 pyramidal
neurons, perhaps to counteract a reduction in activity-dependent
and -independent vesicular GABA release. As well as aberrant
phasic inhibition, we also observed a clear increase in tonic
currents in thalamocortical and layer 5/6 pyramidal neurons of
SSADH2/2 mice compared to WTs. This is not surprising since
GABA levels are approximately 3 fold higher in the cerebrospinal
fluid of SSADH2/2 mice [6]. Given our recent findings in normal
Wistar rats [17], we also suggest that elevated GHB levels,
approximately 40 fold in SSADH2/2 mice, may contribute to
increased tonic inhibition.
Previous studies in SSADH2/2 mice identified no changes in
either spontaneous or evoked IPSCs in layer 2/3 pyramidal
neurons, but did demonstrate a larger tonic current in these
neurons [21], whilst mIPSC frequency and GABAA IPSPs were
reduced in CA1 pyramidal neurons [20,22]. The loss of GABAA
inhibition in CA1 pyramidal neurons is in good agreement with
reduced [35S]tert-butylbicyclophosphorothionate ([35S]TBPS)
binding in the hippocampus of SSADH2/2 mice and a reduction
of b2 subunit, but not a1, b3 or c2 subunits, expression [20,22].
However, reduced [35S]TBPS was also observed in both the cortex
and thalamus of SSADH2/2 mice, but our data and those of
Drasbek et al. (2008) indicate that GABAA receptor function is
either unaltered or increased in these areas. One possible
explanation is that the loss of GABAA receptors in the cortex
and thalamus is an attempt to homeostatically compensate for
increased levels of GABA and GHB, which is ultimately
unsuccessful. However, it must also be born in mind that GABAA
receptor expression as measured by [3H]muscimol or [3H]fluni-
trazepam binding was no different in SSADH2/2 and WT mice
[20]. In any case, taken together, these studies highlight how
changes in GABAA inhibition in the same model of epilepsy may
be cell-type specific, as evidenced by enhanced tonic currents in
thalamocortical neurons, but reduced tonic currents in dentate
gyrus granule cells, of stargazer mice [17,40].
We previously demonstrated enhanced tonic inhibition in
thalamocortical neurons from diverse genetic and pharmacolog-
ical models of absence seizures [17], and these findings are
extended by our present observations in thalamocortical neurons
of SSADH deficient mice. Extrasynaptic GABAA receptors in
thalamocortical neurons are critical for seizure genesis in two of
the best established models of absence, the genetic absence
epilepsy rats from Strasbourg (GAERS) and GHB models, and
their selective activation can induce seizures in normal animals
[17]. It therefore seems likely that increased tonic GABAA
inhibition in thalamocortical neurons is also important for the
appearance of seizures in SSADH deficient mice. However, the
pathological consequences of enhanced phasic inhibition in
thalamic neurons remains to be determined, although increased
frequency and peak amplitude of mIPSCs and loss of IPSC
paired-pulse depression has been documented in NRT neurons of
GAERS [41], that may lead to increased excitability and
hypersynchrony [42]. This does not explain, though, why the
mode of action of clonazepam, a frontline treatment for absence
epilepsy, is to selectively increase phasic inhibition in NRT
neurons [43]. Furthermore, the pro-epileptic role of aberrant
phasic and tonic inhibition, if any, in layer 5/6 cortical neurons
of SSADH2/2 mice, or indeed other models of typical absence
seizures, also remains to be elucidated.
In summary, SSADH deficient mice exhibit synaptic and
extrasynaptic GABAA receptor gain-of-function in cortico-thalam-
ic networks that may underlie the appearance of typical absence
seizures. Such gain-of-function appears to be a defining feature of
typical absence seizures, and may have pathological consequences
in patients deficient for SSADH.
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